About TrimSoMo
Source-linked, factual information about FDA-approved GLP-1 medications, regulatory enforcement records, and obesity medicine providers.
What TrimSoMo is
TrimSoMo is a free, informational resource built for U.S. adults seeking clear, verifiable facts about FDA-approved GLP-1 weight-loss medications (such as Wegovy, Zepbound, Wegovy Tablets, Foundayo, and Saxenda), investigational pipeline candidates, and clinical providers.
TrimSoMo does not sell, dispense, or prescribe medications. We do not provide medical advice or endorse specific commercial clinics. Every factual claim on this site links directly to primary sources, including official FDA prescribing labels, DailyMed records, and federal CMS databases.
Who runs it
TrimSoMo is owned and operated by xcircl, LLC, an independent digital publishing organization registered in the United States.
[CY TO PROVIDE: Founder bio, leadership background, and team credentials]
How we're funded
TrimSoMo displays zero banner advertisements, accepts zero third-party ad networks, and has no paid listing placements. We do not accept sponsored posts or fees from compounding pharmacies or telehealth companies to alter our directories or ratings.
For full transparency regarding our non-commercial stance and operations, please consult our Commercial Disclosure.
How we source facts
Our data pipeline compiles records strictly from authoritative government and regulatory bodies:
- FDA Prescribing Information: Approved indications, active ingredients, dosage forms, and boxed warnings from DailyMed and Drugs@FDA.
- FDA Regulatory Enforcement: Official Warning Letters concerning unapproved or misbranded GLP-1 drugs published on FDA.gov.
- CMS NPPES Registry: Active healthcare providers registered under obesity medicine and bariatric taxonomy codes in the federal National Plan and Provider Enumeration System.
Read our complete data pipeline documentation on our Methodology & Sources page and our Editorial Policy.
Corrections & contact
We are committed to factual accuracy. If you identify an outdated regulatory record, an incorrect provider taxonomy status, or a typographical error, we provide an expedited review process.
Submit verified correction requests via our Data Corrections page.
[CY TO PROVIDE: General contact email address, media inquiries contact, and mailing address]